Thomas A. Mitro
2018
In 2018, Thomas A. Mitro earned a total compensation of $3.4M as President and Chief Operating Officer at Aerie Pharmaceuticals, a 26% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $161,000 |
|---|---|
| Option Awards | $2,139,054 |
| Salary | $460,000 |
| Stock Awards | $684,262 |
| Total | $3,444,316 |
Mitro received $2.1M in option awards, accounting for 62% of the total pay in 2018.
Mitro also received $161K in non-equity incentive plan, $460K in salary and $684.3K in stock awards.
Rankings
In 2018, Thomas A. Mitro's compensation ranked 3,314th out of 14,244 executives tracked by ExecPay. In other words, Mitro earned more than 76.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,314 out of 14,244 | 77th |
Division Manufacturing | 1,225 out of 5,759 | 79th |
Major group Chemicals And Allied Products | 423 out of 2,122 | 80th |
Industry group Drugs | 349 out of 1,811 | 81st |
Industry Biological Products, Except Diagnostic Substances | 76 out of 339 | 78th |
Source: SEC filing on April 10, 2019.
Mitro's colleagues
We found four more compensation records of executives who worked with Thomas A. Mitro at Aerie Pharmaceuticals in 2018.
News
Aerie Pharmaceuticals CEO Vicente Anido's 2021 pay rises 4% to $3.8M
April 26, 2022
Aerie Pharmaceuticals CEO Vicente Anido's 2020 pay falls 35% to $3.6M
April 27, 2021
Aerie Pharmaceuticals CEO Vicente Anido's 2019 pay slips 18% to $5.5M
April 24, 2020
Aerie Pharmaceuticals CEO Vicente Anido's 2018 pay falls 33% to $6.8M
April 10, 2019